Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good day for me:
BHP up 8%
BP up 2%
EXAS up 9%
FIT up 4%
REGI up 6%
RIG up 8%
SOUHY up 3%
TCK up 19%
XIN up 2%
another $8 and I'll be back in the money, lol:
Teck Resources Limited (TCK) -NYSE ?
6.80 Up 0.84(14.03%) 12:56PM EST -
On our way!
Fitbit Inc. (FIT) -NYSE ?
12.83 Up 0.42(3.38%) 11:17AM
Volume:3,794,092
Avg Vol (3m):7,683,860
DUK trading at $73.50
8:01 am Duke Energy prices offering of 9.25 mln shares of common stock $72/share (DUK) : The expected net proceeds from the offering are to be used to finance a portion of the costs of Duke's pending acquisition of Piedmont Natural Gas Company (PNY).
Canadian Pacific Railway Ltd., which is pressing an unwanted takeover bid for Norfolk Southern Corp., recently revived a $20 billion-plus effort to combine with CSX Corp. in the latest sign of its eagerness to bring consolidation to the industry.
http://www.marketwatch.com/story/csx-rebuffed-20-billion-canadian-pacific-merger-offer-2016-03-01?siteid=yhoof2
CSX
Market Cap:23.73B
http://finance.yahoo.com/q?s=CSX
lol- again I say, not worth the $32 it traded at two years ago. Thanks for validating my valuation system
lmao- you are missing out on so much....... shoveling
I tried to pick up more at $4.70ish, but no luck (or maybe it is, lol)
What: Fight Colorectal Cancer, a leading national colorectal cancer nonprofit and Exact Sciences Corp. (EXAS), a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer will visit the Nasdaq MarketSite in Times Square to celebrate the 4th annual kickoff of their awareness campaign One Million Strong and March Colorectal Cancer Awareness Month.
In honor of the occasion, Lt. Gov. Rebecca Kleefisch of Wisconsin and a colon cancer survivor will ring the Closing Bell along with Fight Coloretcal Cancer President Anjee Davis and Kevin Conroy, chairman and CEO of Exact Sciences.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Wednesday, March 2, 2016 – 3:45 p.m. to 4:00 p.m. ET
Fight Colorectal Cancer Media Contact:
Danielle Burgess
(703) 548-1225 ext. 442
danielle@fightcolorectalcancer.org
Exact Sciences Corp. Media Contact:
Jackson Helmer
(608) 210-5170
jhelmer@exactsciences.com
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
emily.pan@nasdaq.com
EXAS down 30% in the last 5 days and down 45% in the last three months. Hmmm- what to do here?
Just a right to buy 250,000 shares at $23.23 starting in 2020 if I'm reading it correctly:
Explanation of Responses:
1. Subject to acceleration upon a "change of control" (as defined) or termination of employment due to death or disability.
XIN: BEIJING, March 1, 2016 /PRNewswire/ -- Xinyuan Real Estate Co., Ltd. ("Xinyuan" or "the Company") (XIN), an NYSE-listed real estate developer and property manager primarily in China and recently in other countries, today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2015 of US$0.025 per common share, or US$0.05 per American Depositary Share (ADS), which will be payable on March 29, 2016 to shareholders of record as of March 15, 2016.
Fourth Quarter 2015 Highlights
•Total fourth quarter revenue increased 13.9% to US$413.6 million from US$362.9 million in the fourth quarter of 2014 and increased 33.9% from US$309.0 million in the third quarter of 2015.
•Contract sales increased 42.6% to US$574.2 million from US$402.6 million in the fourth quarter of 2014 and increased 85.4% from US$309.7 million in the third quarter of 2015.
•Total gross floor area ("GFA") sales increased 66.9% to 420,900 square meters from 252,200 square meters sold in the fourth quarter of 2014 and increased 80.4% from 233,300 square meters sold in the third quarter of 2015.
•Selling, General and Administrative ("SG&A") expenses as a percent of total revenue decreased to 13.3% from 14.6% in the fourth quarter of 2014 and decreased from 15.8% in the third quarter of 2015.
•Net income was US$19.1 million, compared to US$23.8 million in the fourth quarter of 2014 and US$22.7 million in the third quarter of 2015.
•Diluted net earnings per American Depositary Share ("ADS") attributable to shareholders were US$0.26, compared to US$0.30 in the fourth quarter of 2014 and US$0.31 in the third quarter of 2015.
•The Company repurchased 495,759 ADSs at a total cost of approximately US$1.7 million in the fourth quarter of 2015.
Full Year 2015 Highlights
•For the year ended December 31, 2015, total revenues increased 26.6% to US$1,164.3 million from US$919.7 million in 2014. GFA sales increased 56.7% to 986,100 square meters from 629,100 square meters in 2014. Contract sales increased 34.5% to US$1,401.1 million from US$1,041.6 million in 2014.
•Gross profit was US$273.0 million, or 23.4% of revenue in 2015, compared to a gross profit of US$242.2 million, or 26.3% of revenue in 2014. The Company commenced presales on six projects in 2015.
•SG&A expenses were US$167.5 million, or 14.4% of revenue in 2015, compared to US$145.1 million, or 15.8% of revenue in 2014.
•Net income was US$66.5 million in 2015 compared to US$48.5 million in 2014. Diluted earnings per ADS were US$0.91 in 2015 compared to US$0.58 per ADS in 2014.
Nope- I already own it
Spent the last two hours looking for a value play- came up with nothing.
I'm going to have to figure out a new valuation model
Doesn't look like the street cares about the report
Vector Group Ltd. (VGR) -NYSE ?
23.23 Up 0.12(0.52%) 4:02PM EST
After Hours : 23.23 0.00 (0.00%) 4:31PM
Duke Energy announces public offering of common stock in connection with its pending acquisition of Piedmont Natural Gas
http://finance.yahoo.com/news/duke-energy-announces-public-offering-210500978.html
Ouch- EXAS:new 52-week low
Day's Range:5.08 - 5.74
52wk Range:5.08 - 32.85
Volume:1,961,371
Avg Vol (3m):2,060,150
Exact Sciences Corporation (EXAS) -NasdaqCM ? Watchlist
5.24 Down 0.46(8.06%) 2:52PM
Bought FIT at 12.06
lol- it helps ease the pain of some of the other crap in the portfolio
I agree on the oversold. I'm bidding $12ish on it with a goal of $15ish on the sell side. If it breaks the 52-week low, probably will bail
Hmm, I guess I shoulda held a couple more days, lol:
U.S. Silica Holdings, Inc. (SLCA) -NYSE ? Watchlist
19.03 Up 1.14(6.37%) 10:37AM
Still lower then when I sold it, lol
timhyma Member Level Grandfathered Member Wednesday, 02/17/16 12:12:50 PM
Re: EZ2 post# 109216
Post # of 109677
Sold GPRO at $12.88 for a 22% gain from the buy on Feb 2, 2016
Thoughts on FIT?
http://finance.yahoo.com/q?s=FIT
I'm a day trader today. Sold SLCA at $16.08 for a 15% gain. I had a limit order in while I was at a meeting
I'm up a buck already
U.S. Silica Holdings, Inc. (SLCA) -NYSE
14.93 Down 1.43(8.74%) 11:12AM
any thoughts on FIT?
Fitbit Inc. (FIT) -NYSE
12.25 Down 0.83(6.35%) 11:05AM
Took a small position in SLCA at $13.92. I think the sell off is overdone
have you noticed that Greece/Spain isn't in the headlines anymore?
6:06 am EXACT Sciences beats by $0.06, misses on revs; guides FY16 revs in-line (EXAS) :
Reports Q4 (Dec) loss of $0.41 per share, $0.06 better than the Capital IQ Consensus of ($0.47); revenues rose 861.3% year/year to $14.42 mln vs the $14.76 mln Capital IQ Consensus.
•Co issues in-line guidance for FY16, sees FY16 revs of $90-100 mln vs. $94.06 mln Capital IQ Consensus Estimate; continues to anticipate completing more than 240,000 Cologuard tests during 2016
•Exact Sciences ended 2015 with cash, cash equivalents and marketable securities of $306.9 million, compared to $282.8 million at December 31, 2014.
•The cumulative number of physicians ordering Cologuard expanded steadily in 2015. During the fourth quarter of 2015 this total grew 27 percent from the third quarter to nearly 27,000 physicians. On average, approximately 500 new physicians ordered Cologuard each week and 75 percent of physicians re-ordered the FDA-approved, non-invasive colon cancer screening test. The patient compliance rate with Cologuard at the end of 2015 was 71 percent.
U.S. Silica Holdings, Inc. (SLCA) today announced a net loss of $15.3 million or $(0.29) per basic and diluted share for the fourth quarter ended Dec. 31, 2015 compared with net income of $33.2 million or $0.62 per basic share and $0.61 per diluted share for the fourth quarter ended Dec. 31, 2014.
•Net income was $11.9 million or $0.22 per basic share compared with $121.5 million or $2.26 per basic share for the full year 2014.
going lower- Transocean Ltd. (RIG) -NYSE
8.54 Feb 23, 4:02PM EST
Pre-Market : 7.83 Down 0.71 (8.31%) 9:18AM
BHP Billiton Limited (BHP) -NYSE
24.09 Feb 23, 4:01PM EST
Pre-Market : 21.97 Down 2.12 (8.80%) 9:22AM
BHP-Brazilian Police Accuse BHP Execs of Murder (BHP, VALE)
BHP Cuts Dividend for First Time in 15 YearsBloomberg(Tue 8:09AM EST)
BHP Billiton Limited (BHP) -NYSE
24.56 Down 0.73(2.89%) 9:43AM EST -
The dividend cut to 16 cents was more severe than market expectations for a payout as high as 35 cents. BHP ( BHP 2.34% ) pledged a minimum 50% payout of underlying profit going forward.
The old divvy- Div & Yield: 2.48 (10.34%)
wow- kinda quiet around here- markets seems a little short on volume today also.
TCK- looks like we have a short covering situation. About 16% of the O/S is shorted.
Teck Resources Limited (TCK) -NYSE ?
7.14 Up 1.19(20.00%) 10:48AM EST
Volume:7,590,616
Avg Vol (3m):7,832,040
4:43 pm Pfizer receives expanded FDA approval for Ibrance In HR+, HER2 - metastatic breast cancer (PFE) :
•Co announces that the FDA has approved a new indication expanding the use of IBRANCE 125mg capsules, Pfizer's metastatic breast cancer therapy. Now IBRANCE also is approved for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer in combination with fulvestrant in women with disease progression following endocrine therapy.
CSX had some volume today:
Volume:32,691,041
Avg Vol (3m):9,980,360
Coca-Cola (KO) Stock Bubbles Up, Dividend Increased 6%
Look at JACK- disappointed earnings. Missed last two quarters and I get a valuation at $45ish
TCK- up 65% from Thursday's close <vbg>
Teck Resources Limited (TCK) ?
5.92 Up +0.85(+16.77%)